Thank you!

The 2022 Workshop was the most highly attended IBA FDA Cosmetics Regulations Workshop in event history.

Please join us again in 2023! More information coming soon.

In 1983, IBA was chosen by the Food and Drug Administration to create the FDA Cosmetics Regulations Workshop because of its focus on small and mid-sized cosmetic entrepreneurial companies. Government officials and industry experts offer information to help beauty companies comply with regulations.

This two-day event features expert speakers who will learn in-depth about the cosmetic and personal care products industry’s latest issues. These updates include U.S. FDA activities, changes in over-the-counter drug regulations, FDA warning letters and consumer class actions, FTC, NAD, advertising claims and testing, and how to protect your business.

A ‘must-attend’ for anyone responsible for developing, testing, and marketing beauty, personal care, and wellness products.

On-Demand Disclaimer: Important note, the Day 1 session presented by FDA is not permitted to be recorded and will only be available live. The FDA presentations will not be available on-demand. Please plan accordingly! All other presentations will be recorded and available on-demand for registered attendees.

2022 Agenda

  • Day 1, September 21, 2022

     

    12:00 – 12:15 pm ET Welcome
    Donald Frey, President & CEO, IBA
    Craig Weiss, IBA Technical/Regulatory Committee Chair & President, Consumer Product Testing Company
    12:15 – 1:15 pm ETCurrent U.S. FDA Cosmetics Developments
    Linda Katz, M.D., M.P.H., Director, Office of Cosmetics & Colors, Center for Food Safety and Applied Nutrition (CFSAN), FDA
    1:15 – 1:30 pm ETBREAK – Sponsored by CIS 
    1:30 – 2:30 pm ETCurrent U.S. OTC Drug Monograph Developments
    Steven Adah, Ph.D., Associate Director of Monograph, Division of Nonprescription Drug Products, Center for Drug Evaluation and Research (CDER), FDA
    2:30 – 2:45 pm ETBREAK
    2:45 – 3:45 pm ETOMUFA Update 
    Captain Matt Brancazio, Pharm.D., MBA, RAC, CAPT, USPHS, Branch Chief, Policy and Operations Branch, Division of User Fee Management, Office of Management, Center for Drug Evaluation and Research (CDER), FDA 
    3:45 – 4:00 pm ETBREAK
    4:00 – 5:00 pm ETFTC Updates: .com Disclosures Update, Endorsement Guide Update, Green Guides Update 

    Angela Diesch, Partner, Amin Talati Wasserman LLP 

    5:00 – 5:15 pm ETClosing & Adjournment to Day 2  

    Donald Frey, President & CEO, IBA  

    Craig Weiss, IBA Technical/Regulatory Committee Chair & President, Consumer Product Testing Company  

     

  • Day 2, September 22, 2022
     12:00 – 12:15 pm ET Welcome
    Donald Frey, President & CEO, IBA
    Craig Weiss, IBA Technical/Regulatory Committee Chair & President, Consumer Product Testing Company
    12:15 – 1:15 pm ETPFAS Update & Class Action
    Michael J. Duvall, Partner, Dentons US LLP
    Chanell Botshekan, Associate, Dentons US LLP
    1:15 – 1:30 pm ETBREAK
    1:30 – 2:30 pm ETCalifornia Update: CFFIRKA, CARB, Prop 65
    Peter Duchesneau, Partner, Manatt, Phelps & Phillips, LLP
    2:30 – 2:45 pm ETBREAK
    2:45 – 3:45 pm ETInternational Regulatory Hot Topics
    Karen Yarussi-King, IBA Technical/Regulatory Committee Co-Chair & Principal, Global Regulatory Associates
    3:45 – 4:00 pm ETBREAK
    4:00– 5:00 pm ET1,4-Dioxane Deep Dive
    Arielle Brown, Senior Manager, Government Affairs, The American Cleaning InstituteKathleen Stanton, Associate Vice President, Technical & International Affairs, The American Cleaning Institute
    5:00 – 5:15 pm ETClosing & Workshop Adjournment
    Donald Frey, President & CEO, IBA
    Craig Weiss, IBA Technical/Regulatory Committee Chair & President, Consumer Product Testing Company

2022 Sponsors

Diamond

     Platinum

Gold

2022 Featured Speakers

Dr. Linda Katz, M.D., M.P.H.

Capt. Matt Brancazio, Pharm.D., MBA, RAC

Branch Chief, Policy and Operations Branch, Division of User Fee Management, Office of Management

Center for Drug Evaluation and Research (CDER), FDA

Capt. Matt Brancazio, Pharm.D., MBA, RAC

Dr. Steven Adah

Associate Director for Monographs in the Division of Nonprescription Products 1 in the Office of Nonprescription Drugs

Food & Drug Administration

Dr. Steven Adah

Craig Weiss

Karen Yarussi King

President

Global Regulatory Associates

Karen Yarussi King

Michael J. Duvall

Partner

Dentons US LLP

Michael J. Duvall

Chanell Botshekan

Associate

Dentons US LLP

Chanell Botshekan

Peter Duchesneau

Partner

Manatt, Phelps & Phillips, LLP

Peter Duchesneau

Arielle Brown

Senior Manager, Government Affairs

The American Cleaning Institute

Arielle Brown

Kathleen Stanton

Associate Vice President, Technical & International Affairs

The American Cleaning Institute

Kathleen Stanton

Angela Diesch

Partner

Amin Talati Wasserman LLP

Angela Diesch